Biotechnology
Mexican companies specializing in biotechnology
Biotechnology firms research and develop new medical therapies or agricultural processes. Clinical trial outcomes and regulatory decisions routinely drive extreme price action and liquidity across this industry. Currently, Kodiak Sciences, Inc. ranks as the top gainer, and ProKidney Corp. Class A sees maximum volume. The technical and fundamental metrics provided below help quantify these sudden shifts.
Symbol | Mkt cap | Price | Chg % | Vol | Rel vol | P/E | EPS dil TTM | EPS dil growth TTM YoY | Div yield % TTM | Sector | Analyst rating |
|---|---|---|---|---|---|---|---|---|---|---|---|
 AMGNAmgen Inc. | 4.82 T MXN | 8,585.00 MXN | −2.22% | 107 | 0.13 | 27.53 | 311.84 MXN | +31.51% | 2.08% | Health technology | Neutral |
| AMGNAmgen Inc. | 4.82 T MXN | 8,500.00 MXN | +1.42% | 8 | 0.32 | 27.26 | 311.84 MXN | +31.51% | 2.08% | Health technology | Neutral |
 GILDGilead Sciences, Inc. | 4.03 T MXN | 3,146.79 MXN | −4.50% | 12 K | 14.35 | — | −56.95 MXN | −148.12% | 1.86% | Health technology | Buy |
| GILDGilead Sciences, Inc. | 4.03 T MXN | 3,112.62 MXN | −5.54% | 123 | 0.23 | — | −56.95 MXN | −148.12% | 1.86% | Health technology | Buy |
 MRNAModerna, Inc. | 1.92 T MXN | 4,730.00 MXN | +4.94% | 1.69 K | 1.45 | — | −139.77 MXN | +0.90% | 0.00% | Health technology | Neutral |
| MRNAModerna, Inc. | 1.92 T MXN | 4,750.00 MXN | +5.38% | 532 | 0.88 | — | −139.77 MXN | +0.90% | 0.00% | Health technology | Neutral |
 CSL/NCSL Limited | 1.24 T MXN | 2,081.30 MXN | 0.00% | 109 | 0.22 | — | −92.01 MXN | −178.76% | 2.05% | Health technology | Buy |
 ARGX/Nargenx SE Sponsored ADRDR | 1.07 T MXN | 16,611.45 MXN | −1.85% | 31 | 0.06 | 36.17 | 459.27 MXN | +24.46% | 0.00% | Health technology | Strong buy |
 NTRANatera, Inc. | 1.05 T MXN | 6,720.00 MXN | −8.52% | 3 | 0.00 | — | −23.96 MXN | +32.83% | 0.00% | Health technology | Strong buy |
| NTRANatera, Inc. | 1.05 T MXN | 6,720.00 MXN | −11.29% | 22 | 0.35 | — | −23.96 MXN | +32.83% | 0.00% | Health technology | Strong buy |
 IQVIQVIA Holdings Inc | 810.15 B MXN | 5,213.94 MXN | +13.65% | 2.26 K | 1.68 | 35.03 | 148.85 MXN | +11.47% | 0.00% | Health technology | Strong buy |
 GMAB/NGenmab A/S | 596.98 B MXN | 10,784.13 MXN | +30.18% | 701 | 2.76 | 49.86 | 216.27 MXN | −46.59% | 0.00% | Health technology | Buy |
 UTHRUnited Therapeutics Corporation | 486.37 B MXN | 9,680.00 MXN | 0.00% | 152 | 2.59 | 20.19 | 479.39 MXN | −0.89% | 0.00% | Health technology | Buy |
 BNTX/NBioNTech SE Sponsored ADRDR | 424.6 B MXN | 1,710.00 MXN | −0.00% | 8 | 0.12 | — | −137.36 MXN | −357.61% | 0.00% | Health technology | Buy |
 NBIXNeurocrine Biosciences, Inc. | 313.22 B MXN | 3,005.00 MXN | −2.75% | 770 | 3.23 | 24.63 | 121.99 MXN | +58.92% | 0.00% | Health technology | Strong buy |
| NBIXNeurocrine Biosciences, Inc. | 313.22 B MXN | 2,995.92 MXN | −3.36% | 303 | 1.54 | 24.56 | 121.99 MXN | +58.92% | 0.00% | Health technology | Strong buy |
 BBIOBridgeBio Pharma, Inc. | 282.76 B MXN | 1,203.51 MXN | — | 1.9 K | — | — | −54.97 MXN | +28.38% | 0.00% | Health technology | Strong buy |
 HALOHalozyme Therapeutics, Inc. | 275.69 B MXN | 2,370.00 MXN | −3.34% | 52 | 0.06 | 40.45 | 58.59 MXN | −28.66% | 0.00% | Health technology | Buy |
| HALOHalozyme Therapeutics, Inc. | 275.69 B MXN | 2,395.00 MXN | −2.32% | 10 | 0.03 | 40.88 | 58.59 MXN | −28.66% | 0.00% | Health technology | Buy |
 SMMTSummit Therapeutics Inc | 240.99 B MXN | 278.00 MXN | −28.46% | 5 | — | — | −19.59 MXN | −3.67% | 0.00% | Health technology | Buy |
| SMMTSummit Therapeutics Inc | 240.99 B MXN | 290.00 MXN | 0.00% | 1 | 0.00 | — | −19.59 MXN | −3.67% | 0.00% | Health technology | Buy |
 BMRNBioMarin Pharmaceutical Inc. | 206.22 B MXN | 1,021.00 MXN | −7.60% | 10 | 0.03 | — | −1.87 MXN | −103.83% | 0.00% | Health technology | Buy |
 TWSTTwist Bioscience Corp. | 174.92 B MXN | 3,255.37 MXN | +14.31% | 5.22 K | — | — | −38.92 MXN | −42.93% | 0.00% | Health technology | Buy |
 TXG10x Genomics Inc Class A | 163.94 B MXN | 1,160.49 MXN | −4.54% | 16.67 K | 5.29 | — | −10.32 MXN | +21.64% | 0.00% | Health technology | Buy |
| TXG10x Genomics Inc Class A | 163.94 B MXN | 1,160.49 MXN | −14.04% | 50 | — | — | −10.32 MXN | +21.64% | 0.00% | Health technology | Buy |
 KODKodiak Sciences, Inc. | 115.38 B MXN | 1,602.00 MXN | +300.50% | 25 | — | — | −73.40 MXN | −3.20% | 0.00% | Health technology | Strong buy |
| KODKodiak Sciences, Inc. | 115.38 B MXN | 1,835.09 MXN | −0.81% | 1 | 0.00 | — | −73.40 MXN | −3.20% | 0.00% | Health technology | Strong buy |
 CRSP/NCRISPR Therapeutics AG | 93.59 B MXN | 950.00 MXN | 0.00% | 3 | 0.03 | — | −85.86 MXN | +16.06% | 0.00% | Health technology | Buy |
 BEAMBeam Therapeutics, Inc. | 53.6 B MXN | 510.00 MXN | +6.25% | 10 | 0.03 | — | −18.90 MXN | +76.76% | 0.00% | Health technology | Strong buy |
| BEAMBeam Therapeutics, Inc. | 53.6 B MXN | 538.00 MXN | +5.49% | 20 | 0.37 | — | −18.90 MXN | +76.76% | 0.00% | Health technology | Strong buy |
 RXRXRecursion Pharmaceuticals, Inc. Class A | 45.07 B MXN | 66.57 MXN | +0.86% | 21.51 K | 35.70 | — | −16.14 MXN | +51.35% | 0.00% | Health technology | Buy |
| RXRXRecursion Pharmaceuticals, Inc. Class A | 45.07 B MXN | 64.08 MXN | −4.94% | 73 | 0.85 | — | −16.14 MXN | +51.35% | 0.00% | Health technology | Buy |
 BCRXBioCryst Pharmaceuticals, Inc. | 39.24 B MXN | 149.50 MXN | −1.64% | 1.04 K | 1.66 | — | −25.70 MXN | −2,864.02% | 0.00% | Health technology | Strong buy |
| BCRXBioCryst Pharmaceuticals, Inc. | 39.24 B MXN | 151.13 MXN | +0.22% | 13 | 0.03 | — | −25.70 MXN | −2,864.02% | 0.00% | Health technology | Strong buy |
 NVAXNovavax, Inc. | 32.74 B MXN | 198.15 MXN | +7.78% | 210 | 0.55 | — | −26.66 MXN | −162.96% | 0.00% | Health technology | Buy |
| NVAXNovavax, Inc. | 32.74 B MXN | 201.00 MXN | +12.92% | 14.76 K | 15.82 | — | −26.66 MXN | −162.96% | 0.00% | Health technology | Buy |
 QURE/NuniQure N.V. | 29.77 B MXN | 397.29 MXN | −41.65% | 590 | 1.81 | — | −70.86 MXN | +3.66% | 0.00% | Health technology | Strong buy |
 CMPS/NCOMPASS Pathways Plc Sponsored ADRDR | 22.71 B MXN | 240.00 MXN | 0.00% | 4 | 1.25 | — | −63.29 MXN | −28.83% | 0.00% | Health technology | Strong buy |
 ALT1Altimmune, Inc. | 7.69 B MXN | 45.50 MXN | −14.05% | 2 K | 34.91 | — | −13.81 MXN | +37.49% | 0.00% | Health technology | Strong buy |
| ALT1Altimmune, Inc. | 7.69 B MXN | 38.00 MXN | −10.06% | 113 | 0.11 | — | −13.81 MXN | +37.49% | 0.00% | Health technology | Strong buy |
 PROKProKidney Corp. Class A | 6.31 B MXN | 19.54 MXN | −2.30% | 60.77 K | 2.69 | — | −9.67 MXN | +8.67% | 0.00% | Health technology | Buy |
| PROKProKidney Corp. Class A | 6.31 B MXN | 20.42 MXN | −14.92% | 2.1 K | 0.04 | — | −9.67 MXN | +8.67% | 0.00% | Health technology | Buy |
 BBOTBridgeBio Oncology Therapeutics, Inc. | 3.44 B MXN | 59.60 MXN | −7.27% | 25.98 K | — | — | −21,579.34 MXN | −573,291.14% | 0.00% | Health technology | Strong buy |
| BBOTBridgeBio Oncology Therapeutics, Inc. | 3.44 B MXN | 42.50 MXN | −20.43% | 30 K | — | — | −21,579.34 MXN | −573,291.14% | 0.00% | Health technology | Strong buy |
 SPROSpero Therapeutics, Inc. | 1.16 B MXN | 20.54 MXN | −0.68% | 20.77 K | — | 10.75 | 1.91 MXN | — | 0.00% | Health technology | Strong buy |
| SPROSpero Therapeutics, Inc. | 1.16 B MXN | 22.31 MXN | +1.69% | 20.5 K | 0.40 | 11.67 | 1.91 MXN | — | 0.00% | Health technology | Strong buy |
 FLNAFilana Therapeutics, Inc. | 514.95 M MXN | 10.80 MXN | −4.42% | 8 | 1.38 | — | −15.32 MXN | +68.06% | 0.00% | Health technology | Strong buy |
 BNGOBionano Genomics, Inc. | 309.96 M MXN | 21.60 MXN | −1.82% | 10 | 0.06 | — | −65.30 MXN | +92.24% | 0.00% | Health technology | Strong buy |
| BNGOBionano Genomics, Inc. | 309.96 M MXN | 22.00 MXN | −2.65% | 264 | 4.44 | — | −65.30 MXN | +92.24% | 0.00% | Health technology | Strong buy |